Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intralesional Methotrexate Versus Intramuscular Methotrexate in the Treatment of Non-melanoma Skin Cancers

NCT05315128 is registered in ClinicalTrials.gov with Zagazig University as lead sponsor.

NCT NCT05315128
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05315128 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intralesional Methotrexate Versus Intramuscular Methotrexate in the Treatment of Non-melanoma Skin Cancers
Lead sponsor
Zagazig University
Phase
Phase 2
Overall status
Completed
Start date
July 6, 2020
Completion date
December 6, 2021
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-melanoma skin cancers